合成路线1
该中间体在本合成路线中的序号:
(C) The alkylation of p-chloroaniline (V) as before yields N-(2,2,2-trifluoroethyl)aniline (VI), which is then condensed with aziridine (C) affording the substituted aniline (VII). The benzoylation of (VII) with 2-fluorobenzoyl chloride (D) yields the amide (VIII), which is cyclized with P2O5 in refluxing POCl3 giving 7-chloro-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-5-(2-fluorophenyl)-1,4-benzodiazepine (IX). This compound is oxidized with RuO4 in CCl4 to give 7-chloro-1-(2,2,2-trifluoroethyl)-1,3-dihydro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one (I), which by reaction with P2S5 in refluxing dioxane gives the target compound.
【1】
Steinman, M.; Benzodiazepines and the process for their manufacture. DE 2138773; ES 393953; FR 2102114; GB 1345938 .
|
【2】
Steinman, M.; 1-Polyfluoroalkyl-1,4-benzodiazepin-2-thiones for effecting tranquilization, sedation and treating colvulsions. US 3920818 .
|
【3】
Castaner, J.; Thorpe, P.; Quazepam. Drugs Fut 1978, 3, 2, 139.
|
【4】
Topliss, J.G.; Steinman, M.; Alekel, R.; Wong, Y.S.; York, E.E.; 1-Polyfluoroalkylbenzodiazepines. J Med Chem 1973, 16, 12, 1354-60.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
19551 |
2-Fluorobenzoyl chloride
|
393-52-2 |
C7H4ClFO |
详情 | 详情
|
(A) |
33474 |
2,2,2-Trifluoroethyl trichloromethanesulfonate; 2,2,2-Trifluoroethyl trichloromethylsulfonate
|
23199-56-6 |
C3H2Cl3F3O3S |
详情 | 详情
|
(I) |
33471 |
7-Chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
|
|
C17H11ClF4N2O |
详情 |
详情
|
(V) |
12034 |
4-Chlorophenylamine; 4-Chloroaniline; p-Chloroaniline
|
106-47-8 |
C6H6ClN |
详情 | 详情
|
(VI) |
33475 |
N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine; 4-chloro-N-(2,2,2-trifluoroethyl)aniline
|
|
C8H7ClF3N |
详情 |
详情
|
(VII) |
33476 |
N(1)-(4-chlorophenyl)-N(1)-(2,2,2-trifluoroethyl)-1,2-ethanediamine; N-(2-aminoethyl)-N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine
|
|
C10H12ClF3N2 |
详情 |
详情
|
(VIII) |
33477 |
N-[2-[4-chloro(2,2,2-trifluoroethyl)anilino]ethyl]-2-fluorobenzamide
|
|
C17H15ClF4N2O |
详情 |
详情
|
(IX) |
33478 |
7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine; 7-chloro-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-5-(2-fluorophenyl)-1,4-benzodiazepine
|
|
C17H13ClF4N2 |
详情 |
详情
|
(C) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) By reaction of [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (I) with ethyleneimine (II) in refluxing CHCl3.
【1】
Scolastico, C.; Tronconi, G.; DE 2711149 .
|
【2】
de Angelis, L.; Pirinixil. Drugs Fut 1979, 4, 4, 273.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
39473 |
2-[[4-chloro-6-(2,3-dimethylanilino)-2-pyrimidinyl]sulfanyl]acetic acid
|
50892-23-4 |
C14H14ClN3O2S |
详情 | 详情
|
(II) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(IV) The reaction of chloranil (I) with ethyl carbamate (II) by means of Na in dry benzene gives 2,5-dichloro-3,6-bis(ethoxycarbonylamino)-1,4-benzoquinone (III), which is then condensed with aziridine (IV) by means of triethylamine in THF.
【1】
Driscoll, J.S.; et al.; Structure-antitumor activity relationships among quinone derivatives. Cancer Chemother Rep 1974, 4, 2, 1.
|
【2】
Zubrod, C.G.; Rall, D.P.; Anu Rev Pharmacol 1962, 2, 109.
|
【3】
Kahn, A.H.; Driscoll, J.S.; Potential central nervous system antitumor agents. Azirinylbenzoquinones. 1. J Med Chem 1976, 19, 2, 313-317.
|
【4】
Driscoll, J.S.; et al. (US Department of Health & Human Services); Aziridinyl quinone anti-transplanted tumor agents. US 4146622 .
|
【5】
Cabanillas, F.; Blancafort, P.; Serradell, M.N.; Castaner, J.; AZQ. Drugs Fut 1981, 6, 6, 338.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21891 |
2,3,5,6-Tetrachloro-1,4-benzoquinone; 2,3,5,6-Tetrachlorobenzo-1,4-quinone; p-Chloranil
|
118-75-2 |
C6Cl4O2 |
详情 | 详情
|
(II) |
24199 |
Ethyl carbamate; Urethane
|
51-79-6 |
C3H7NO2 |
详情 | 详情
|
(III) |
32193 |
2,5-Dichloro-3,6-bis(ethoxycarbonylamino)-1,4-benzoquinone; Ethyl 2,5-dichloro-4-[(ethoxycarbonyl)amino]-3,6-dioxo-1,4-cyclohexadien-1-ylcarbamate
|
|
C12H12Cl2N2O6 |
详情 |
详情
|
(IV) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) By reaction of 1,3,3,5,5-pentachloro-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide (I) with aziridine (II) in ether.
【1】
Van der Huizen, A.A.; Sournies, F.; Labarre, J.F.; Van der Grampel, J.C.; Wiedijk, D.; Jekel, A.P.; Derivatives of cis-NPCl2(NSOCl)2 and (NPCl2)2 NSOCl. Part XVI. The preparation of some aziridino (ethyleneimino) derivatives of (NPCl2)2 NSOX (X=F,Az,Ph) with a potential anticancer activity. Inorg Chim Acta 1981, 53, 4, 169-170. |
【2】
Labarre, J.F.; Sournies, F.; Van der Grampel, J.; Van der Huizen, A. (ANVAR (Agence Natl. Valor. Rech.)); Inorganocyclic cpds. usable as medicaments and a process for their preparation. EP 0022407 .
|
【3】
Blancafort, P.; Castaner, J.; Serradell, M.N.; Hopkins, S.J.; SOAz. Drugs Fut 1983, 8, 7, 605.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36151 |
1,3,3,5,5-pentachloro-1lambda(6),2,4,6,3lambda(5),5lambda(5)-thiatriazadiphosphinin-1-one
|
|
Cl5N3OP2S |
详情 |
详情
|
(II) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(VII) [2H]-Labeled RSU-1069 is synthesized as follows:
The condensation of 2-nitroimidazole (I) with 3-chloro-1,2-epoxypropane (II) gives 1-(3-chloro-2-hydroxypropyl)-2-nitroimidazole (III), which is oxidized with CrO3 - H2SO4 in acetone yielding 1-(3-chloro-2-oxopropyl)-2-nitroimidazole (IV). The reduction of (IV) with NaB[2H]4 in ethanol affords 1-(3-chloro-2-hydroxy-2(2H)-propyl)-2-nitroimidazole (V), which is cyclized with NaOH to the corresponding labeled epoxide (VI). Finally, this compound is condensed with aziridine (VII) by means of triethylamine in refluxing ethanol.
【1】
Webb, P.; Threadgill, M.D.; Labelled compounds of interest as antitumour agents. Part II (1). Synthesis of 2H and 3H isotopomers of RSU 1069 and Ro 03-8799 (pimonidazole). J Label Compd Radiopharm 1990, 28, 3, 257.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III),(V) |
10147 |
1-Chloro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol
|
|
C6H8ClN3O3 |
详情 |
详情
|
(I) |
10145 |
2-Nitro-1H-imidazole; 2-Nitroimidazole
|
527-73-1 |
C3H3N3O2 |
详情 | 详情
|
(II) |
10146 |
Epichlorohydrin; 2-(Chloromethyl)oxirane
|
106-89-8 |
C3H5ClO |
详情 | 详情
|
(IV) |
10148 |
1-Chloro-3-(2-nitro-1H-imidazol-1-yl)acetone
|
|
C6H6ClN3O3 |
详情 |
详情
|
(V) |
44588 |
1-chloro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol
|
|
C6H8ClN3O3 |
详情 |
详情
|
(VI) |
10150 |
2-Nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(VI) |
44589 |
2-nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(VII) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) By reaction of 1-(2,3-epoxypropyl)-2-nitroimidazole (I) with aziridine (II) in refluxing methanol.
【1】
Foster, J.L.; Deutsh, G.; Parnell, M.; McFadzean, J.A.; Human studies with "high dose" metronidazole; a non-toxic radiosensitizer of hypoxic cells. Brit J Cancer 1984, 49, 1, 571.
|
【2】
Ahmed, I.; Adams, G.E.; Stratford, I.J. (National Research Development Corp.); Aziridino containing nitro imidazoles and pharmaceutical compositions. EP 0095906; GB 2123816; JP 58225086; US 4596817; US 4631289; US 4757148 .
|
【3】
Hopkins, S.J.; Castaner, J.; RSU-1069. Drugs Fut 1986, 11, 6, 467.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10150 |
2-Nitro-1-(2-oxiranylmethyl)-1H-imidazole
|
|
C6H7N3O3 |
详情 |
详情
|
(II) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(III) Title compound can be prepared by two different ways:
1) The reaction of 1,4,7,10-tetraoxa-13-azacyclopentandecane (I) with phosphoryl chloride in the presence of triethylamine in diethyl ether gives 13-(dichlorophosphoryl)-1,4,7,10-tetraoxa-13-azacyclopentandecane (II), which is subsequently reacted with aziridine (III) in the presence of triethylamine to give azacrown-TEPA.
2) The reaction of the aziridine (III) with phosphoryl chloride in the presence of triethylamine in diethyl ether gives bis(1-aziridinyl)chlorophosphine oxide (IV), which is subsequently reacted with 1,4,7,10-tetraoxa-13-azacyclopentandecane (I) in the presence of triethylamine to afford azacrown-TEPA.
【1】
Okahara, M.; Nakatsuji, Y.; Maeda, H.; Facile synthesis of monoaza crown ethers. J Med Chem 1981, II, 471-472.
|
【2】
Lukszo, J.; Sosnovsky, G.; Azacrown-TEPA. Drugs Fut 1985, 10, 4, 275.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29102 |
1,4,7,10-tetraoxa-13-azacyclopentadecane
|
66943-05-3 |
C10H21NO4 |
详情 | 详情
|
(II) |
29103 |
1,4,7,10-tetraoxa-13-azacyclopentadecan-13-ylphosphonic dichloride
|
|
C10H20Cl2NO5P |
详情 |
详情
|
(III) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(IV) |
29104 |
di(1-aziridinyl)phosphinic chloride
|
|
C4H8ClN2OP |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(C) The reaction of 4-chloro-N-(2,2,2-trifluoroethyl)aniline (V) with ethyleneimine (C) by means of AlCl3 in benzene affords the N-(2-aminoethyl) compound (VI), which is benzoylated with benzoyl chloride (D) as usual yielding the benzamide (VII). Compound (VII) is cyclized with P2O5 in POCl3 giving 7-chloro-1,2-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine (VIII), which is finally oxidized with RuO4.
【1】
Topliss, J.G.; Steinman, M.; Alekel, R.; Wong, Y.S.; York, E.E.; 1-Polyfluoroalkylbenzodiazepines. J Med Chem 1973, 16, 12, 1354-60.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(D) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(V) |
33475 |
N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine; 4-chloro-N-(2,2,2-trifluoroethyl)aniline
|
|
C8H7ClF3N |
详情 |
详情
|
(VI) |
33476 |
N(1)-(4-chlorophenyl)-N(1)-(2,2,2-trifluoroethyl)-1,2-ethanediamine; N-(2-aminoethyl)-N-(4-chlorophenyl)-N-(2,2,2-trifluoroethyl)amine
|
|
C10H12ClF3N2 |
详情 |
详情
|
(VII) |
33850 |
N-[2-[4-chloro(2,2,2-trifluoroethyl)anilino]ethyl]benzamide
|
|
C17H16ClF3N2O |
详情 |
详情
|
(VIII) |
33851 |
7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine
|
|
C17H14ClF3N2 |
详情 |
详情
|
(C) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) The cyclization of piperidine-2-carboxylic acid ethyl ester (I) with aziridine (II) in ethanol gives perhydropyrido[1,2-a]pyrazin-1-one (III), which is reduced with LiAlH4 to yield perhydropyrido[1,2-a]pyrazine (IV). The reaction of (IV) with NaNO2/HCl, followed by reduction with LiAlH4, affords perhydropyrido[1,2-a]pyrazin-2-amine (V), which is finally condensed with rifamicin SV-3-carbaldehyde (VI).
【1】
Hauffe, S.; Tosch, W.; Batt, E.; Ashtekar, D.R.; Costa-Pereira, R.; Vischer, W.; Traxler, P.; Degen, P.; Zak, O.; Imhof, P.; Gowrishankar, R.; 3-Formylrifamycin SV-hydrazones with diazabicycloalkyl side-chains: New rifamycins aganist tuberculosis with long plasma half-lives. 27th Intersci Conf Antimicrob Agents Chemother 1987, Abst 278. |
【2】
Ashtekar, D.R.; Vischer, W.; Kump, W.; Costa-Pereira, R.; Traxler, P.; Subrahmanyam, D.; Gowrishankar, R.; Antitubercular activity in vitro and in vivo of new long-acting rifamycin derivatives. Bull Intl Union Tuberc 1986, 61, 3, 8.
|
【3】
Traxler, P. (Novartis Corp.); Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compsns. for treating tuberculosis. US 4681938 .
|
【4】
Traxler, P.; Vischer, W.; Zak, O.; New Rifamycins. Drugs Fut 1988, 13, 9, 845.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
43693 |
ethyl 2-piperidinecarboxylate
|
15862-72-3 |
C8H15NO2 |
详情 | 详情
|
(II) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(III) |
43694 |
hexahydro-2H-pyrido[1,2-a]pyrazin-1(6H)-one
|
|
C8H14N2O |
详情 |
详情
|
(IV) |
43695 |
octahydro-2H-pyrido[1,2-a]pyrazine
|
|
C8H16N2 |
详情 |
详情
|
(V) |
43696 |
octahydro-2H-pyrido[1,2-a]pyrazin-2-ylamine; octahydro-2H-pyrido[1,2-a]pyrazin-2-amine
|
|
C8H17N3 |
详情 |
详情
|
(VI) |
43692 |
26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
|
|
C38H47NO13 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(A) Ethyleneimine is reacted with tetrafluoro-1.4-benzoquinone (I) in the cold to form 2,5-diaziridinyl-3,6-difluoro-1-4-benzoquinone (II). The reaction with ethanolamine at room temperature results in BZQ, which is recrystallized from ethanol.
【1】
Chou, F.; et al.; Potential central nervous system antitumor agents. Aziridinylbenzoquinones. J Med Chem 1976, 19, 11, 1302.
|
【2】
Bosanquet, A.G.; BZQ. Drugs Fut 1986, 11, 1, 12.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(B) |
10259 |
Ethanol amine;Ethanolamine;2-Aminoethanol; 2-Amino-1-ethanol;2-Aminoethyl alcohol |
141-43-5 |
C2H7NO |
详情 | 详情
|
(I) |
24122 |
2,3,5,6-tetrafluorobenzo-1,4-quinone
|
527-21-9 |
C6F4O2 |
详情 | 详情
|
(II) |
24123 |
2,5-di(1-aziridinyl)-3,6-difluorobenzo-1,4-quinone
|
|
C10H8F2N2O2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(II) The cyclization of 5-ethylpiperidine-2-carboxylic acid ethyl ester (I) with aziridine (II) in ethanol gives 7-ethylperhydropyrido[1,2-a]pyrazin-1-one (III), which is reduced with LiAlH4 to yield 7-ethylperhydropyrido[1,2-a]pyrazine (IV). The reaction of (IV) with NaNO2/HCl, followed by reduction with LiAlH4, affords 7-ethylperhydropyrido[1,2-a]pyrazin-2-amine (V), which is finally condensed with rifamicin SV-3-carbaldehyde (VI).
【1】
Hauffe, S.; Tosch, W.; Batt, E.; Ashtekar, D.R.; Costa-Pereira, R.; Vischer, W.; Traxler, P.; Degen, P.; Zak, O.; Imhof, P.; Gowrishankar, R.; 3-Formylrifamycin SV-hydrazones with diazabicycloalkyl side-chains: New rifamycins aganist tuberculosis with long plasma half-lives. 27th Intersci Conf Antimicrob Agents Chemother 1987, Abst 278. |
【2】
Traxler, P. (Novartis Corp.); Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compsns. for treating tuberculosis. US 4681938 .
|
【3】
Traxler, P.; Vischer, W.; Zak, O.; New Rifamycins. Drugs Fut 1988, 13, 9, 845.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
43688 |
ethyl 5-ethyl-2-piperidinecarboxylate
|
|
C10H19NO2 |
详情 |
详情
|
(II) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(III) |
43689 |
7-ethylhexahydro-2H-pyrido[1,2-a]pyrazin-1(6H)-one
|
|
C10H18N2O |
详情 |
详情
|
(IV) |
43690 |
7-ethyloctahydro-2H-pyrido[1,2-a]pyrazine
|
|
C10H20N2 |
详情 |
详情
|
(V) |
43691 |
7-ethyloctahydro-2H-pyrido[1,2-a]pyrazin-2-amine; 7-ethyloctahydro-2H-pyrido[1,2-a]pyrazin-2-ylamine
|
|
C10H21N3 |
详情 |
详情
|
(VI) |
43692 |
26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate
|
|
C38H47NO13 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) The condensation of aziridine (I) with methyl 4-hydroxybenzoate (II) in refluxing chloroform gives methyl 4-(2-aminoethoxy)benzoate (III), which is acylated with 4-isopropylbenzoyl chloride by means of K2CO3 in chloroform yielding methyl 4-[2-(4-isopropylbenzamido)ethoxy]benzoate (IV). Finally, this compound is hydrolyzed with NaOH in refluxing water.
【1】
Yoshikuni, Y.; Choaki, S.; Ozaki, T.; Yoshida, H. (Nippon Shinyaku Co., Ltd.); Benzoic acid derivs. CH 674204; DE 3718765; FR 2600059; GB 2191487; JP 1987292754; JP 1988159359; US 4831055 .
|
【2】
Prous, J.; Castaner, J.; NS-1. Drugs Fut 1990, 15, 7, 682.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
41310 |
4-isopropylbenzoyl chloride
|
|
C10H11ClO |
详情 |
详情
|
(I) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(II) |
10251 |
methyl 4-hydroxybenzoate; Methyl p-hydroxybenzoate
|
99-76-3 |
C8H8O3 |
详情 | 详情
|
(III) |
12457 |
methyl 4-(2-aminoethoxy)benzoate
|
|
C10H13NO3 |
详情 |
详情
|
(IV) |
12458 |
methyl 4-[2-[(4-isopropylbenzoyl)amino]ethoxy]benzoate
|
|
C20H23NO4 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(XXIII) 1) The nitrosation of 3-chlorophenol (I) with NaNO2 and H2SO4 in water gives 3-chloro-4-nitrophenol (III), which is methylated with SO4(Me)2 and NaH in THF to yield 3-chloro-4-nitroanisole (IV). The condensation of (IV) with ethyl cyanoacetate (V) by means of NaH in DMF affords ethyl 2-(5-methoxy-2-nitrophenyl)cyanoacetate (VI), which is submitted to ethanolysis with ethanol/HCl affording the malonic ester derivative (VII). The hydrogenation of (VII) with H2 over PtO2 in toluene/ethanol gives the corresponding amino derivative (VIII), which is condensed with methyl 3-formylacrylate (IX) in ethanol yielding the intermediate imine (X). This imine (X), without isolation, is cyclized with zinc acetate in methanol affording 3-[3,3-bis(ethoxycarbonyl)-5-methoxy-2,3-dihydro-1H-indol-2-yl]acrylic acid methyl ester (XI), which is acetylated with acetic anhydride to the N-acetyl derivative (XII). The decarboxylative hydrolysis of (XII) with KOH in ethanol gives 3-(1-acetyl-3-carboxy-5-methoxy-2,3-dihydro-1H-indol-2-yl)acrylic acid (XIII), which is converted into its dimethyl ester (XIV) with SO4(Me)2 and K2CO3. The dehydrogenation of (XIV) with dichlorodicyanobenzoquinone (DDQ) in refluxing toluene yields 3-[1-acetyl-5-methoxy-3-(methoxycarbonyl)-1H-indol-2-yl]acrylic acid methyl ester (XV), which is deacetylated to (XVI) by column chromatography over basic alumina in dichloromethane/acetone. The nitration of (XVI) with fuming nitric acid in acetic acid affords the 4-nitro derivative (XVII), which is methylated with NaH and methyl iodide to the N-methyl derivative (XVIII). The reduction of (XVIII) with Sn and 3N HCl in ethanol/water yields the corresponding 4-amino derivative (XIX), which is oxidized with Fremy's salt (nitrodisulfonic acid potassium salt) to afford 3-[5-methoxy-3-(methoxycarbonyl)-1-methyl-4,7-dioxo-4,7-dihydro-1H-indo l -2-yl]acrylic acid methyl ester (XX). The reduction of (XX) with Na2S2O4 in CHCl3/ethanol/water gives the corresponding hydroquinone (XXI), which is first reduced with DIBAL (diisobutylaluminum hydride) in toluene/dichloromethane and then oxidized again with FeCl3 to afford 3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-5-methoxy-1-methyl-4,7-dihydro-1H-indole-4,7-dione (XXII). Finally, this compound is treated with aziridine (XXIII) in hot methanol.
【1】
Bailey, S.M.; Lohmeyer, M.; Dimbleby, R.; Castaner, J.; EO9. Drugs Fut 1996, 21, 2, 143.
|
【2】
Oostveen, E.A.; Speckamp, W.N.; Mitomycin analogues I. Indoloquinones as (potential) bisalkylating agents. Tetrahedron 1987, 43, 255-62.
|
【3】
Speckamp, W.N.; Oostveen, E.A. (University of Amsterdam); Indoloquinone cpds. JP 1989502906; US 5079257; WO 8706227 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12597 |
3-Chlorophenol; m-Chlorophenol
|
108-43-0 |
C6H5ClO |
详情 | 详情
|
(II) |
12598 |
3-Chloro-4-nitrosophenol
|
|
C6H4ClNO2 |
详情 |
详情
|
(III) |
12599 |
3-Chloro-4-nitrophenol
|
491-11-2 |
C6H4ClNO3 |
详情 | 详情
|
(IV) |
12600 |
3-Chloro-4-nitrophenyl methyl ether; 2-Chloro-4-methoxy-1-nitrobenzene; 3-Chloro-4-nitroanisole
|
28987-59-9 |
C7H6ClNO3 |
详情 | 详情
|
(V) |
11877 |
Cyanoacetic acid ethyl ester; Ethyl 2-cyanoacetate; Ethyl cyanoacetate; Ethyl isocyanacetate
|
105-56-6 |
C5H7NO2 |
详情 | 详情
|
(VI) |
12602 |
ethyl 2-cyano-2-(5-methoxy-2-nitrophenyl)acetate
|
|
C12H12N2O5 |
详情 |
详情
|
(VII) |
12603 |
diethyl 2-(5-methoxy-2-nitrophenyl)malonate
|
|
C14H17NO7 |
详情 |
详情
|
(VIII) |
12604 |
diethyl 2-(2-amino-5-methoxyphenyl)malonate
|
|
C14H19NO5 |
详情 |
详情
|
(IX) |
12605 |
methyl (E)-4-oxo-2-butenoate
|
7327-99-3 |
C5H6O3 |
详情 | 详情
|
(X) |
12606 |
diethyl 2-(5-methoxy-2-[[(E,2E)-4-methoxy-4-oxo-2-butenylidene]amino]phenyl)malonate
|
|
C19H23NO7 |
详情 |
详情
|
(XI) |
12607 |
diethyl 5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1,2-dihydro-3H-indole-3,3-dicarboxylate
|
|
C19H23NO7 |
详情 |
详情
|
(XII) |
12608 |
diethyl 1-acetyl-5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1,2-dihydro-3H-indole-3,3-dicarboxylate
|
|
C21H25NO8 |
详情 |
详情
|
(XIII) |
12609 |
1-Acetyl-2-[(E)-2-carboxyethenyl]-5-methoxy-3-indolinecarboxylic acid
|
|
C15H15NO6 |
详情 |
详情
|
(XIV) |
12610 |
methyl 1-acetyl-5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-3-indolinecarboxylate
|
|
C17H19NO6 |
详情 |
详情
|
(XV) |
12611 |
methyl 1-acetyl-5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1H-indole-3-carboxylate
|
|
C17H17NO6 |
详情 |
详情
|
(XVI) |
12612 |
methyl 5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1H-indole-3-carboxylate
|
|
C15H15NO5 |
详情 |
详情
|
(XVII) |
12613 |
methyl 5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-4-nitro-1H-indole-3-carboxylate
|
|
C15H14N2O7 |
详情 |
详情
|
(XVIII) |
12614 |
methyl 5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1-methyl-4-nitro-1H-indole-3-carboxylate
|
|
C16H16N2O7 |
详情 |
详情
|
(XIX) |
12615 |
methyl 4-amino-5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1-methyl-1H-indole-3-carboxylate
|
|
C16H18N2O5 |
详情 |
详情
|
(XX) |
12616 |
methyl 5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1-methyl-4,7-dioxo-4,7-dihydro-1H-indole-3-carboxylate
|
|
C16H15NO7 |
详情 |
详情
|
(XXI) |
12617 |
methyl 4,7-dihydroxy-5-methoxy-2-[(E)-3-methoxy-3-oxo-1-propenyl]-1-methyl-1H-indole-3-carboxylate
|
|
C16H17NO7 |
详情 |
详情
|
(XXII) |
12618 |
3-(Hydroxymethyl)-2-[(E)-3-hydroxy-1-propenyl]-5-methoxy-1-methyl-1H-indole-4,7-dione
|
|
C14H15NO5 |
详情 |
详情
|
(XXIII) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(XXIII) 2) The esterification of 2-hydroxy-3-methoxybenzaldehyde (XXIV) with methanesulfonyl chloride and triethylamine gives the corresponding mesylate (XXV), which is nitrated with fuming HNO3 to 2-(methanesulfonyloxy)-3-methoxy-6-nitrobenzaldehyde (XXVI). The condensation of (XXVI) or 2-(benzenesulfonyloxy)-3-methoxy-6-nitrobenzaldehyde (XXVIII) with 2-(diethoxyphosphoryl)acetic acid methyl ester by means of NaH in THF yields 3-(2-hydroxy-3-methoxy-6-nitrophenyl)acrylic acid methyl ester (XXVII), which is benzylated with benzyl bromide and K2CO3 to the benzyl derivative (XXIX). The cyclization of (XXIX) with refluxing triethyl phosphite affords 4-benzyloxy-5-methoxy-1H-indole-2-carboxylic acid methyl ester (XXX), which is reduced to the corresponding carbaldehyde (XXXI) according to Tetrahedron Lett 1994, 50: 7657. The methylation of (XXXI) with NaH and methyl iodide in DMF yields the N-methyl derivative (XXXII), which is condensed with 2-(diethoxyphosphoryl)acetic acid methyl ester by means of NaH in THF to afford 3-(4-benzyloxy-5-methoxy-1-methylindol-2-yl)acrylic acid methyl ester (XXXIII). The formylation of (XXXIII) with POCl3 and DMF gives the 4-formyl derivative (XXXIV), which is debenzylated with trimethylsilyl iodide in acetonitrile to the 4-hydroxy compound (XXXV). The oxidation of (XXXV) with Fremy's salt as before yields 3-(3-formyl-5-methoxy-1-methyl-4,7-dioxo-4,7-dihydro-1H-indole-2-yl) acrylic acid methyl ester (XXXVI), which is treated successively with Na2S2O4, DIBAL, and finally with FeCl3, as before, to afford the dihydroxy quinone (XXII), already obtained.
【1】
Cotterill, A.S.; Moody, C.J.; Roffey, J.R.; An improved synthesis of the indolequinone anticancer agent EO9. Tetrahedron 1995, 51, 26, 7223-30.
|
【2】
Bailey, S.M.; Lohmeyer, M.; Dimbleby, R.; Castaner, J.; EO9. Drugs Fut 1996, 21, 2, 143.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
27698 |
methyl 2-(diethoxyphosphoryl)acetate
|
1067-74-9 |
C7H15O5P |
详情 | 详情
|
(XXII) |
12618 |
3-(Hydroxymethyl)-2-[(E)-3-hydroxy-1-propenyl]-5-methoxy-1-methyl-1H-indole-4,7-dione
|
|
C14H15NO5 |
详情 |
详情
|
(XXIII) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(XXIV) |
12620 |
o-Vanillin; 2-Hydroxy-3-methoxybenzaldehyde
|
148-53-8 |
C8H8O3 |
详情 | 详情
|
(XXV) |
12621 |
2-formyl-6-methoxyphenyl methanesulfonate
|
|
C9H10O5S |
详情 |
详情
|
(XXVI) |
12622 |
2-formyl-6-methoxy-3-nitrophenyl methanesulfonate
|
|
C9H9NO7S |
详情 |
详情
|
(XXVII) |
12623 |
methyl (E)-3-(2-hydroxy-3-methoxy-6-nitrophenyl)-2-propenoate
|
|
C11H11NO6 |
详情 |
详情
|
(XXVIII) |
12624 |
2-formyl-6-methoxy-3-nitrophenyl benzenesulfonate
|
|
C14H11NO7S |
详情 |
详情
|
(XXIX) |
12625 |
methyl (E)-3-[2-(benzyloxy)-3-methoxy-6-nitrophenyl]-2-propenoate
|
|
C18H17NO6 |
详情 |
详情
|
(XXX) |
12626 |
methyl 4-(benzyloxy)-5-methoxy-1H-indole-2-carboxylate
|
|
C18H17NO4 |
详情 |
详情
|
(XXXI) |
12627 |
4-(Benzyloxy)-5-methoxy-1H-indole-2-carbaldehyde
|
|
C17H15NO3 |
详情 |
详情
|
(XXXII) |
12628 |
4-(Benzyloxy)-5-methoxy-1-methyl-1H-indole-2-carbaldehyde
|
|
C18H17NO3 |
详情 |
详情
|
(XXXIII) |
12629 |
ethyl (E)-3-[4-(benzyloxy)-5-methoxy-1-methyl-1H-indol-2-yl]-2-propenoate
|
|
C22H23NO4 |
详情 |
详情
|
(XXXIV) |
12630 |
ethyl (E)-3-[4-(benzyloxy)-3-formyl-5-methoxy-1-methyl-1H-indol-2-yl]-2-propenoate
|
|
C23H23NO5 |
详情 |
详情
|
(XXXV) |
12631 |
ethyl (E)-3-(3-formyl-4-hydroxy-5-methoxy-1-methyl-1H-indol-2-yl)-2-propenoate
|
|
C16H17NO5 |
详情 |
详情
|
(XXXVI) |
12632 |
ethyl (E)-3-(3-formyl-5-methoxy-1-methyl-4,7-dioxo-4,7-dihydro-1H-indol-2-yl)-2-propenoate
|
|
C16H15NO6 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(XXIII) 3) The cyclization of benzoquinone (XXXVII) with 3-amino-4-methoxycrotonic acid methyl ester (XXXVIII) gives 5-hydroxy-2-(methoxymethyl)-1H-indole-3-carboxylic acid methyl ester (XXXIX), which is methylated to 5-methoxy-2-(methoxymethyl)-1-methylindole-3-carboxylic acid methyl ester (XL). The oxidation of (XL) with DDQ yields the corresponding aldehyde (XLI), which is submitted to a Horner-Emmonds condensation with 2-(dimethoxyphosphoryl)acetic acid ethyl ester (XLII) in a basic medium to afford the corresponding acrylic ester (XLIII). The nitration of (XLIII) gives 3-[5-methoxy-3-(methoxycarbonyl)-1-methyl-4-nitroindol-2-yl]acrylic acid ethyl ester (XLIV), the monoethyl ester analogue of compound (XVIII).The reduction of (XLIV) with Sn and 3N HCl in ethanol/water yields the corresponding 4-amino derivative (XLV), which is oxidized with Fremy's salt (nitrodisulfonic acid potassium salt) to afford 3-[5-methoxy-3-(methoxycarbonyl)-1-methyl-4,7-dioxo-4,7-dihydro-1H-indo l -2-yl]acrylic acid ethyl ester (XLVI). The reduction of (XLVI) with Na2S2O4 in CHCl3/ethanol/water gives the corresponding hydroquinone (XLVII), which is first reduced with DIBAL (diisobutylaluminum hydride) in toluene/dichloromethane and then oxidized again with FeCl3 to afford 3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-5-methoxy-1-methyl-4,7-dihydro-1H-indole-4,7-dione (XXII). Finally, this compound is treated with aziridine (XXIII) in hot methanol.
【1】
Bailey, S.M.; Lohmeyer, M.; Dimbleby, R.; Castaner, J.; EO9. Drugs Fut 1996, 21, 2, 143.
|
【2】
Kinugawa, M.; Arai, H.; Nishikawa, H.; Masuda, Y.; Ogasa, T.; Tomioka, S.; Kasai, M.; Synthetic studies of the indoloquinone antitumor agent EO9. 13th Int Symp Med Chem (Sept 19-23, Paris) 1994, Abst P250.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXII) |
12618 |
3-(Hydroxymethyl)-2-[(E)-3-hydroxy-1-propenyl]-5-methoxy-1-methyl-1H-indole-4,7-dione
|
|
C14H15NO5 |
详情 |
详情
|
(XXIII) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(XXXVII) |
12633 |
Quinone; Benzo-1,4-quinone; 2,5-Cyclohexadiene-1,4-dione
|
106-51-4 |
C6H4O2 |
详情 | 详情
|
(XXXVIII) |
12634 |
methyl (E)-3-amino-4-methoxy-2-butenoate
|
|
C6H11NO3 |
详情 |
详情
|
(XXXIX) |
12635 |
methyl 5-hydroxy-2-(methoxymethyl)-1H-indole-3-carboxylate
|
|
C12H13NO4 |
详情 |
详情
|
(XL) |
12636 |
methyl 5-methoxy-2-(methoxymethyl)-1-methyl-1H-indole-3-carboxylate
|
|
C14H17NO4 |
详情 |
详情
|
(XLI) |
12637 |
methyl 2-formyl-5-methoxy-1-methyl-1H-indole-3-carboxylate
|
|
C13H13NO4 |
详情 |
详情
|
(XLII) |
10019 |
Ethyl 2-(diethoxyphosphoryl)acetate; Triethyl phosphonoacetate
|
867-13-0 |
C8H17O5P |
详情 | 详情
|
(XLIII) |
12639 |
methyl 2-[(E)-3-ethoxy-3-oxo-1-propenyl]-5-methoxy-1-methyl-1H-indole-3-carboxylate
|
|
C17H19NO5 |
详情 |
详情
|
(XLIV) |
12640 |
methyl 2-[(E)-3-ethoxy-3-oxo-1-propenyl]-5-methoxy-1-methyl-4-nitro-1H-indole-3-carboxylate
|
|
C17H18N2O7 |
详情 |
详情
|
(XLV) |
63466 |
2-propenyl 6-(1-hydroxyethyl)-3-({5-[2-(5-isothiazolyl)ethenyl]-1-[(2-propenyloxy)carbonyl]-3-pyrrolidinyl}sulfanyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
|
|
C26H31N3O6S2 |
详情 |
详情
|
(XLVI) |
63467 |
methyl 2-[(E)-3-ethoxy-3-oxo-1-propenyl]-5-methoxy-1-methyl-4,7-dioxo-4,7-dihydro-1H-indole-3-carboxylate
|
|
C17H17NO7 |
详情 |
详情
|
(XLVII) |
63468 |
methyl 2-[(E)-3-ethoxy-3-oxo-1-propenyl]-4,7-dihydroxy-5-methoxy-1-methyl-1H-indole-3-carboxylate
|
|
C17H19NO7 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(IX) Ethyl 5-hydroxy-2-methylindole (I) was dimethylated with iodomethane in the presence of KH to give (II). Nitration of (II) in AcOH afforded the 4-nitroindole (III) together with some 6-nitro isomer (IV), which were separated by column chromatography. Reduction of (III) with Sn and HCl yielded the 4-aminoindole (V). This was then oxidized with Fremy's salt to afford the corresponding indolequinone (VI) (1). Quinone (VI) was reduced to the hydroquinone (VII) with sodium dithionite, and this was further reduced with DIBAL-H to give, after oxidative work-up with FeCl3 to regenerate the quinone, the 3-(hydroxymethyl) indolequinone (VIII). Finally, substitution of the methoxy group of (VIII) with aziridine (IX) in DMF yielded the target compound (2).
【1】
Beall, H.D.; Winski, S.; Swann, E.; Hudnott, A.R.; Cotterill, A.S.; O'Sullivan, N.; Green, S.J.; Bien, R.; Siegel, D.; Ross, D.; Moody, C.J.; Indolequinone antitumor agents: Correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity. J Med Chem 1998, 41, 24, 4755. |
【2】
Naylor, M.A.; et al.; Indolequinone antitumor agents: Reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro. J Med Chem 1998, 41, 15, 2720.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26100 |
3-Carbethoxy-5-hydroxy-2-methylindole; 5-Hydroxy-2-methylindole-3-carboxylic acid ethyl ester; 5-Hydroxy-2-methyl-1H-indole-3-carboxylic acid ethyl ester
|
7598-91-6 |
C12H13NO3 |
详情 | 详情
|
(II) |
26101 |
ethyl 5-methoxy-1,2-dimethyl-1H-indole-3-carboxylate
|
|
C14H17NO3 |
详情 |
详情
|
(III) |
26102 |
ethyl 5-methoxy-1,2-dimethyl-4-nitro-1H-indole-3-carboxylate
|
|
C14H16N2O5 |
详情 |
详情
|
(IV) |
26103 |
ethyl 5-methoxy-1,2-dimethyl-6-nitro-1H-indole-3-carboxylate
|
|
C14H16N2O5 |
详情 |
详情
|
(V) |
26104 |
ethyl 4-amino-5-methoxy-1,2-dimethyl-1H-indole-3-carboxylate
|
|
C14H18N2O3 |
详情 |
详情
|
(VI) |
26105 |
ethyl 5-methoxy-1,2-dimethyl-4,7-dioxo-4,7-dihydro-1H-indole-3-carboxylate
|
|
C14H15NO5 |
详情 |
详情
|
(VII) |
26106 |
ethyl 4,7-dihydroxy-5-methoxy-1,2-dimethyl-1H-indole-3-carboxylate
|
|
C14H17NO5 |
详情 |
详情
|
(VIII) |
26107 |
3-(hydroxymethyl)-5-methoxy-1,2-dimethyl-1H-indole-4,7-dione
|
|
C12H13NO4 |
详情 |
详情
|
(IX) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(XIV) Acylation of aziridine (XIV) with methanesulfonyl chloride produced sulfonamide (XV). This was then condensed with piperidine (XIII) to yield the target sulfonylaminoethyl piperidine.
【1】
Kowalczyk, B.A.; et al.; Process development of the synthetic route to sulamserod hydrochloride. Org Process Res Dev 2001, 5, 2, 116.
|
【2】
Clark, R.D.; Eglen, R.; Jahangir, A.; Miller, A.B.; Gardner, J.O. (Syntex (USA), Inc.); Novel 1-phenylalkanone 5-HT4 receptor ligands. EP 0700383; JP 1996510743; WO 9427965 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIII) |
35641 |
1-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(4-piperidinyl)-1-propanone
|
|
C16H21ClN2O3 |
详情 |
详情
|
(XIV) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(XV) |
35642 |
1-(methylsulfonyl)aziridine
|
|
C3H7NO2S |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(IV) 2-(Hydroxymethyl)-5-methyl-1,4-benzoquinone (III) was obtained by hydroxymethylation of toluhydroquinone (I) with formaldehyde, followed by oxidation of the resulting hydroquinone (II) with Ag2O. Then, addition of aziridine (IV) to quinone (III) furnished the title compound.
【1】
Remers, W.A.; Witty, T.R.; Synthesis and antitumor and antibacterial activity of benzoquinones related to the mitomycins. J Med Chem 1973, 16, 11, 1280.
|
【2】
Winski, S.L.; Hargreaves, R.H.J.; Butler, J.; Ross, D.; A new screening system for NAD(P)H: quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin Cancer Res 1998, 4, 12, 3083. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45525 |
2-methyl-1,4-benzenediol
|
95-71-6 |
C7H8O2 |
详情 | 详情
|
(II) |
45526 |
2-(hydroxymethyl)-5-methyl-1,4-benzenediol
|
|
C8H10O3 |
详情 |
详情
|
(III) |
45527 |
2-(hydroxymethyl)-5-methylbenzo-1,4-quinone
|
|
C8H8O3 |
详情 |
详情
|
(IV) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(I) The reaction of aziridine (I) with hydrazine gives aminoethylhydrazine (II) (1), which is then cyclized with ethyl 2,3-diphenylpropionimidate hydrochloride (III) in ethanol. (1,2)
【1】
Trepanier, D.L. (Dow Chem. Co.); US 3471486 .
|
【2】
Trepanier, D.L.; et al.; Vitrase approved by FDA as spreading agent; phase III results in vitreous hemorrhage also presented. J Med Chem 1969, 12, 2, 257.
|
【3】
Castaner, J.; Hillier, K.; DL - 262. Drugs Fut 1979, 4, 3, 196.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(II) |
41188 |
2-hydrazinoethylamine; 2-hydrazino-1-ethanamine
|
|
C2H9N3 |
详情 |
详情
|
(III) |
61383 |
ethyl 2,3-diphenylpropanimidoate hydrochloride
|
|
C17H20ClNO |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XI) Protection of 1,5,6,7-tetrahydroindol-4-one (I) with Boc2O by means of t-BuOK in refluxing THF gives the corresponding N-Boc-indolone (II), which is then reduced with H2 over Pt/C in MeOH to yield (3aR*, 4S*,7aR*)-cis-N-Boc-4-hydroxyoctahydroindole (III). Swern oxidation of alcohol (III) using (COCl)2, DMSO and Et3N in THF affords the racemic perhydroindolone (IV), which is resolved using chiral chromatography to the (3aR,7aR)-enantiomer (V). Alternatively, enantioselective acetylation of racemic alcohol (III) with vinyl acetate in the presence of immobilized Candida antarctica lipase (Novozyme 435), followed by flash chromatographic separation of the undesired (3aS,4R,7aS)-acetate provides unreacted (3aR,4S,7aR)-alcohol (VI), which is then oxidized to ketone (V) under Swern conditions. Treatment of 1-ethynyl-3-methylbenzene (VII) with BuLi in THF at –20 °C and subsequent enantioselective condensation with ketone (V) leads to propargylic alcohol (VIII), which is then N-deprotected with HCl in EtOAc to produce the amine (IX). Finally, amine (IX) is acylated with methyl chloroformate (X) in the presence of Et3N in CH2Cl2 .
Alternatively, Michael addition of aziridine (XI) to 2-cyclohexenone (XII) in toluene gives 3-(1-aziridinyl)cyclohexanone (XIII), which is submitted to aziridine ring opening by treatment with methyl chloroformate in toluene to provide methyl N-2-chloroethyl-N-(3-oxocyclohexyl)carba-mate (XIV). Intramolecular cyclization of carbamate (XIV) in the presence of pyrrolidine and Et3N in CH2Cl2 affords racemic methyl 4-oxooctahydroindole-1-carboxylate (XV), which is then subjected to chiral chromatographic separation, resulting in the (3aR,7aR)-enantiomer (XVI). Finally, 1-ethynyl-3-methylbenzene (VII) is stereospecifically added to ketone (XVI) in the presence of n-Hex-Li in THF .
【1】
Auberson, Y., Ofner, S., Gasparini, F. (Novartis AG; Novartis Pharma GmbH). Acetylene derivatives having mGluR5 antagonistic activity. EP 1453512, JP 2005514381, JP 200830326, US 200506591, US 7348353, US 2008146647, US 2008303226, WO 2003047581. |
【2】
Kuesters, E., Acemoglu, M., Lustenberger, P., Sedelmeier, G., Schmidt, B.,Penn, G. (Novartis AG). Processes for the preparation of 4-oxo-octahydroindole-1-carbocylic acid methyl ester and derivatives thereof. CN 102119151, EP 2315748, JP 2011530566, KR 2011042222, US 2011144352, US 8084487, WO 2010018154. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68376 |
6,7-dihydro-1H-indol-4(5H)-one;1,5,6,7-tetrahydro-4h-indol-4-one;4-0xo-4,5,6,7-tetrahydroindole;4-Oxo-1,5,6,7-tetrahydroindole |
13754-86-4 |
C8H9NO |
详情 | 详情
|
(II) |
68377 |
tert-butyl 4-oxo-4,5,6,7-tetrahydro-1H-indole-1-carboxylate |
|
C13H17NO3 |
详情 | 详情
|
(III) |
68378 |
racemic N-Boc-4-hydroxyoctahydroindole;racemic tert-butyl 4-hydroxyoctahydro-1H-indole-1-carboxylate |
|
C13H23NO3 |
详情 | 详情
|
(IV) |
68379 |
racemic tert-butyl 4-oxooctahydro-1H-indole-1-carboxylate |
|
C13H21NO3 |
详情 | 详情
|
(V) |
68380 |
(3aR,7aR)-tert-butyl 4-oxooctahydro-
1H-indole-1-carboxylate |
|
C13H21NO3 |
详情 | 详情
|
(VI) |
68381 |
(3aR,4S,7aR)-cis-N-Boc-4-
hydroxyoctahydroindole;(3aR,4S,7aR)-tert-butyl 4-
hydroxyoctahydro-1H-indole-1-carboxylate |
|
C13H23NO3 |
详情 | 详情
|
(VII) |
68382 |
1-ethynyl-3-methylbenzene;3-Ethynyltoluene;3-Methylphenylacetylene;3'-Methylphenylacetylene |
766-82-5 |
C9H8 |
详情 | 详情
|
(VIII) |
68384 |
(3aR,4S,7aR)-tert-butyl 4-hydroxy-4-(m-tolylethynyl)octahydro-1H-indole-1-carboxylate |
|
C22H29NO3 |
详情 | 详情
|
(IX) |
68383 |
(3aR,4S,7aR)-4-(m-tolylethynyl)octahydro-1H-indol-4-ol hydrochloride |
|
C17H21NO.HCl |
详情 | 详情
|
(X) |
16993 |
methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate |
79-22-1 |
C2H3ClO2 |
详情 | 详情
|
(XI) |
10151 |
Ethyleneimine; Aziridine; Azirane
|
151-56-4 |
C2H5N |
详情 | 详情
|
(XII) |
26253 |
2-cyclohexen-1-one;Cyclohex-2-enone;2-cyclohexenone |
930-68-7 |
C6H8O |
详情 | 详情
|
(XIII) |
68385 |
3-(1-aziridinyl)cyclohexanone;3-(aziridin-1-yl)cyclohexanone |
|
C8H13NO |
详情 | 详情
|
(XIV) |
68386 |
methyl N-2-chloroethyl-N-(3-oxocyclohexyl)
carbamate;methyl (2-chloroethyl)(3-oxocyclohexyl)carbamate |
|
C10H16ClNO3 |
详情 | 详情
|
(XV) |
68387 |
racemic methyl 4-oxooctahydroindole-1-carboxylate |
|
C10H15NO3 |
详情 | 详情
|
(XVI) |
68388 |
(3aR,7aR)-methyl 4-oxooctahydro-1H-indole-1-carboxylate |
|
C10H15NO3 |
详情 | 详情
|